Fish biodiversity benefits nutrition, particularly for lower income people

Households in Cambodia caught and consumed a far more diverse array of fish than they sold at market, highlighting how biodiversity loss might affect people’s nutrition, especially for those with lower incomes. 

NIH grant awarded to investigate how immune system can banish HIV

Weill Cornell Medicine has received $4.2 million to study how the immune system in some people infected with HIV can keep the virus under control, which could lead to new therapies.

Machine learning helps define subtypes of Parkinson’s disease

Researchers at Weill Cornell Medicine have used machine learning to define three subtypes of Parkinson’s disease based on the pace at which the disease progresses.

Jamey Edwards is on a mission to fix healthcare

The newest episode of the Startup Cornell podcast features Jamey Edwards '96 MBA '03, president & chief strategy officer at Koko Home, a company providing radar driven, AI-enabled solutions for healthcare and an Entrepreneur in Residence of StartUp Health, which was founded in 2011 to invest in global health entrepreneurs.

Around Cornell

E. coli variant may cause antimicrobial resistance in dogs, humans

Researchers studying antimicrobial-resistant E. coli – the leading cause of human death due to antimicrobial resistance worldwide – have identified a mechanism in dogs that may render multiple antibiotic classes ineffective.

NIH funds consortium to speed TB treatment development

A new consortium co-led by Weill Cornell Medicine has been awarded a five-year, $31 million grant from the NIH’s National Institute of Allergy and Infectious Diseases to accelerate the development of better treatment regimens for tuberculosis.

Researchers customize AI tools for digital pathology

Scientists from Weill Cornell Medicine and the Dana-Farber Cancer Institute have developed new AI tools tailored to digital pathology, a growing field that uses high-resolution digital images created from tissue samples to help diagnose disease.

Study backs RSV vaccine safety during pregnancy

Vaccinating mothers against RSV during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.

Diversity in typhoid bacteria linked to higher mortality rates

One in five of the bacterial strains that cause typhoid fever have genetic variations in their external layer, called Vi capsule, that provide higher virulence, higher infectivity and high antibiotic resistance, Cornell researchers have discovered.